The company
InMed Pharmaceuticals Inc. - Common Shares
INM · Nasdaq
INM stood above a rising 150-day average in 15 of the last 52 weekly readings, including each of the last 15 weeks. It is 8.8% above that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Leading
- Weeks in an uptrend
- 15 in a row
- Industry in uptrend
- 16% -15 in 4 wk
- Insider buys, 12 months
- $2.6M
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 19 (+12)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 15 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Adar1 Capital Management, Llc10% owner | bought | 1,086at $1.32 | 19 Oct 2026filed 20 Oct 2026 |
| Adar1 Capital Management, Llc10% owner | bought | 1at $1.32 | 16 Oct 2026filed 20 Oct 2026 |
| Adar1 Capital Management, Llc10% owner | bought | 984at $1.32 | 15 Oct 2026filed 15 Oct 2026 |
| Adar1 Capital Management, Llc10% owner | bought | 8,021at $1.33 | 14 Oct 2026filed 15 Oct 2026 |
| Adar1 Capital Management, Llc10% owner | bought | 564at $1.33 | 13 Oct 2026filed 15 Oct 2026 |
| Adar1 Capital Management, Llc10% owner | bought | 2,256at $1.33 | 8 Oct 2026filed 8 Oct 2026 |
| Adar1 Capital Management, Llc10% owner | bought | 3,046at $1.33 | 7 Oct 2026filed 8 Oct 2026 |
| Adar1 Capital Management, Llc10% owner | bought | 5,601at $1.33 | 6 Oct 2026filed 8 Oct 2026 |
| Adar1 Capital Management, Llc10% owner | bought | 18,182at $1.33 | 5 Oct 2026filed 5 Oct 2026 |
| Adar1 Capital Management, Llc10% owner | bought | 8,307at $1.33 | 2 Oct 2026filed 5 Oct 2026 |
| Adar1 Capital Management, Llc10% owner | bought | 16,431at $1.33 | 1 Oct 2026filed 5 Oct 2026 |
| Adar1 Capital Management, Llc10% owner | bought | 8,340at $1.29 | 16 Sep 2026filed 16 Sep 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| ADAR1 Capital Management, LLCnew · filed 14 Aug 2026 | 800,000$1.2M | +800,000 |
| Vivo Capital, LLCnew · filed 14 Aug 2026 | 798,377$1.2M | +798,377 |
| Squadron Capital Management LLCnew · filed 14 Aug 2026 | 325,000$504K | +325,000 |
| Ikarian Capital, LLCnew · filed 14 Aug 2026 | 245,025$380K | +245,025 |
| Ursa Fund Management, LLCnew · filed 14 Aug 2026 | 125,800$195K | +125,800 |
| MONTANOVA CAPITAL, LLCnew · filed 14 Aug 2026 | 100,000$155K | +100,000 |
| BOOTHBAY FUND MANAGEMENT, LLCnew · filed 14 Aug 2026 | 74,244$115K | +74,244 |
| SABBY MANAGEMENT, LLCreduced · filed 14 Aug 2026 | 44,970$70K | -175,290−79.6% |
| JANE STREET GROUP, LLCnew · filed 14 Aug 2026 | 43,078$67K | +43,078 |
| Venrock Adviser, LLCnew · filed 14 Aug 2026 | 32,685$51K | +32,685 |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.